𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Single-institute phase 2 study of thalidomide treatment for refractory or relapsed multiple myeloma: Prognostic factors and unique toxicity profile

✍ Scribed by Yutaka Hattori; Shin-ichiro Okamoto; Naoki Shimada; Tsunayuki Kakimoto; Kunihiko Morita; Yusuke Tanigawara; Yasuo Ikeda


Book ID
108584174
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
309 KB
Volume
99
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.